• EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy.
    • Schmidt MK, Kelly JE, Brédart A, Cameron DA, de Boniface J, Easton DF, Offersen BV, Poulakaki F, Rubio IT, Sardanelli F, Schmutzler R, Spanic T, Weigelt B, Rutgers EJT.
    • Eur J Cancer. 2022 Dec 13 [2023 Mar];181:79-91. doi: 10.1016/j.ejca.2022.11.036. Epub ahead of print.
    • Exploring the role of a multidisciplinary hereditary gynecologic oncology clinic in epithelial ovarian cancer risk-reducing surgical decision-making practices: A mixed-methods study.
    • Casalino S, Bruce S, Serfas K, Altman AD, Kean S, Lambert P, McManus KJ, Hartley JN, Nachtigal MW.
    • J Genet Couns. 2023 Feb 20. doi: 10.1002/jgc4.1684. Epub ahead of print.
    • High-dose chemotherapy with stem cell rescue to treat stage III homologous deficient breast cancer: factors influencing clinical implementation.
    • Verbeek JGE, de Jong VMT, Wijnja HM, Jager A, Linn SC, Retèl VP, van Harten WH.
    • BMC Cancer. 2023 Jan 7;23(1):26. doi: 10.1186/s12885-022-10412-x.
    • Providers' perspectives on the reproductive decision-making of BRCA-positive women.
    • Dason ES, Drost L, Greenblatt EM, Scheer AS, Han J, Sobel M, Allen L, Jacobson M, Doshi T, Wolff E, McMahon E, Jones CA.
    • BMC Womens Health. 2022 Dec 8;22(1):506. doi: 10.1186/s12905-022-02093-2.
    • Genetic testing for patients at risk of hereditary breast and ovarian cancer.
    • DeTroye A, Gabbett K, Yi C, Judice M, Luu V, Nelson B, Gregory T.
    • JAAPA. 2022 Oct 1;35(10):48-52. doi: 10.1097/01.JAA.0000873796.81961.da.
    • Talking about Risk, UncertaintieS of Testing IN Genetics (TRUSTING): development and evaluation of an educational programme for healthcare professionals about BRCA1 & BRCA2 testing.
    • Fallowfield L, Solis-Trapala I, Starkings R, May S, Matthews L, Eccles D, Evans DG, Turnbull C, Crawford G, Jenkins V.
    • Br J Cancer. 2022 Oct;127(6):1116-1122. doi: 10.1038/s41416-022-01871-x. Epub 2022 Jun 17.
    • Integrating hereditary breast and ovarian cancer genetic counselling and testing into mainstream clinical practice: Legal and ethical challenges.
    • Charron M, Kaiser B, Dauge A, Gallois H, Lapointe J, Dorval M, Nabi H, Joly Y.
    • Crit Rev Oncol Hematol. 2022 Oct;178:103797. doi: 10.1016/j.critrevonc.2022.103797. Epub 2022 Aug 27.
    • Review
    • Mainstream germline genetic testing for patients with epithelial ovarian cancer leads to higher testing rates and a reduction in genetics-related healthcare costs from a healthcare payer perspective.
    • Bokkers K, Frederix GWJ, Velthuizen ME, van der Aa M, Gerestein CG, van Dorst EBL, Lange JG, Louwers JA, Koole W, Zweemer RP, Ausems MGEM.
    • Gynecol Oncol. 2022 Oct;167(1):115-122. doi: 10.1016/j.ygyno.2022.08.011. Epub 2022 Aug 26.
    • Polygenic risk scores and risk-stratified breast cancer screening: Familiarity and perspectives of health care professionals.
    • Lapointe J, Buron AC, Mbuya-Bienge C, Dorval M, Pashayan N, Brooks JD, Walker MJ, Chiquette J, Eloy L, Blackmore K, Turgeon A, Lambert-Côté L, Leclerc L, Dalpé G, Joly Y, Knoppers BM, Chiarelli AM, Simard J, Nabi H.
    • Genet Med. 2022 Sep 3:S1098-3600(22)00892-9. doi: 10.1016/j.gim.2022.08.001. Epub ahead of print.
    • Experience with a nurse-driven genetic counseling pathway of Italian women with uninformative BRCA test result.
    • Blondeaux E, Lambertini M, Buzzatti G, Bruzzone C, Baraga M, Pisani R, Del Mastro L, Pronzato P, Varesco L, Bonelli L.
    • J Genet Couns. 2022 Aug 29. doi: 10.1002/jgc4.1630. Epub ahead of print.
    • Educational Programme for Cancer Nurses in Genetics, Health Behaviors and Cancer Prevention: A Multidisciplinary Consensus Study.
    • Diez de Los Rios de la Serna C, Fernández-Ortega P, Lluch-Canut T.
    • J Pers Med. 2022 Jul 5;12(7):1104. doi: 10.3390/jpm12071104.
    • Positive experiences of healthcare professionals with a mainstreaming approach of germline genetic testing for women with ovarian cancer.
    • Bokkers K, Zweemer RP, Koudijs MJ, Stehouwer S, Velthuizen ME, Bleiker EMA, Ausems MGEM.
    • Fam Cancer. 2022 Jul;21(3):295-304. doi: 10.1007/s10689-021-00277-7. Epub 2021 Oct 7.
    • Pilot study of an online training program to increase genetic literacy and communication skills in oncology healthcare professionals discussing BRCA1/2 genetic testing with breast and ovarian cancer patients.
    • Meiser B, Woodward P, Gleeson M, Kentwell M, Fan HM, Antill Y, Butow PN, Boyle F, Best M, Taylor N, Bell K, Tucker K.
    • Fam Cancer. 2022 Apr;21(2):157-166. doi: 10.1007/s10689-021-00261-1. Epub 2021 May 10.
    • Nurse-led decision coaching by specialized nurses for healthy BRCA1/2 gene mutation carriers - adaptation and pilot testing of a curriculum for nurses: a qualitative study.
    • Berger-Höger B, Vitinius F, Fischer H, Beifus K, Köberlein-Neu J, Isselhard A, Töpper M, Wiedemann R, Rhiem K, Schmutzler R, Stock S, Steckelberg A.
    • BMC Nurs. 2022 Feb 10;21(1):42. doi: 10.1186/s12912-022-00810-8.
    • Hereditary cancer panel testing challenges and solutions for the latinx community: costs, access, and variants.
    • Douglas MP, Lin GA, Trosman JR, Phillips KA.
    • J Community Genet. 2022 Feb;13(1):75-80. doi: 10.1007/s12687-021-00563-y. Epub 2021 Nov 6.
    • A Survey of the Awareness and Educational Needs of Nurses in Nagasaki Prefecture Regarding Hereditary Breast and Ovarian Cancer.
    • Matsumoto M, Sasaki N, Tsukigawa Y, Otsubo R, Yano H, Nagayasu T.
    • J Cancer Educ. 2022 Jan 6. doi: 10.1007/s13187-022-02132-4. Epub ahead of print.
    • Implementation of Multigene Germline and Parallel Somatic Genetic Testing in Epithelial Ovarian Cancer: SIGNPOST Study.
    • Chandrasekaran D, Sobocan M, Blyuss O, Miller RE, Evans O, Crusz SM, Mills-Baldock T, Sun L, Hammond RFL, Gaba F, Jenkins LA, Ahmed M, Kumar A, Jeyarajah A, Lawrence AC, Brockbank E, Phadnis S, Quigley M, El Khouly F, Wuntakal R, Faruqi A, Trevisan G, Casey L, Burghel GJ, Schlecht H, Bulman M, Smith P, Bowers NL, Legood R, Lockley M, Wallace A, Singh N, Evans DG, Manchanda R.
    • Cancers (Basel). 2021 Aug 27;13(17):4344. doi: 10.3390/cancers13174344.
    • Effect of a health literacy training program for surgical oncologists and specialized nurses on disparities in referral to breast cancer genetic testing.
    • van der Giessen JAM, van Dulmen S, Velthuizen ME, van den Muijsenbergh METC, van Engelen K, Collée M, van Dalen T, Aalfs CM, Hooning MJ, Spreeuwenberg PMM, Fransen MP, Ausems MGEM.
    • Breast. 2021 Aug;58:80-87. doi: 10.1016/j.breast.2021.04.008. Epub 2021 Apr 22.
    • Psychosocial factors related to BRCA1/2 disclosures.
    • Timbs M.
    • Nursing. 2021 Apr 1;51(4):58-61. doi: 10.1097/01.NURSE.0000733956.47297.e6.
    • Knowledge and perceptions of BRCA1/2 genetic testing and needs of diverse women with a personal or family history of breast cancer in South Florida.
    • Jones T, Howard H, Freeman-Costin K, Creighton A, Wisdom-Chambers K, Underhill-Blazey M.
    • J Community Genet. 2021 Jul;12(3):415-429. doi: 10.1007/s12687-021-00507-6. Epub 2021 Feb 8.
    • Implementation of a High-Risk Breast Clinic for Comprehensive Care of Women With Elevated Breast Cancer Risk Identified by Risk Assessment Models in the Community.
    • Laws A, Mulvey TM.
    • JCO Oncol Pract. 2021 Feb;17(2):e217-e225. doi: 10.1200/OP.20.00256. Epub 2020 Aug 21.
    • Communication about breast cancer genetic counseling with patients with limited health literacy or a migrant background: evaluation of a training program for healthcare professionals.
    • van der Giessen J, Fransen MP, Spreeuwenberg P, Velthuizen M, van Dulmen S, Ausems MGEM.
    • J Community Genet. 2020 Dec 15. doi: 10.1007/s12687-020-00497-x. Epub ahead of print.
    • A review of inherited cancer susceptibility syndromes.
    • Brown GR, Simon M, Wentling C, Spencer DM, Parker AN, Rogers CA.
    • JAAPA. 2020 Dec;33(12):10-16. doi: 10.1097/01.JAA.0000721648.46099.2c.
    • A systematic review of communication interventions to help healthcare professionals discuss genetic testing for breast cancer.
    • Starkings R, Shilling V, Jenkins V, Fallowfield L.
    • Breast Cancer Res Treat. 2020 Jun 23. doi: 10.1007/s10549-020-05741-z. Epub ahead of print.
    • How to improve the identification of patients with cancer eligible for genetic counselling?
    • Bracci R, Gasperini B, Capalbo M, Campanelli T, Caimmi E, Mattioli R, Espinosa E, Prospero E.
    • Eur J Cancer Care (Engl). 2020 Jun 8:e13276. doi: 10.1111/ecc.13276. Epub ahead of print.
    • Implementation and evaluation of a nurse-led decision-coaching program for healthy breast cancer susceptibility gene (BRCA1/2) mutation carriers: a study protocol for the randomized controlled EDCP-BRCA study.
    • Isselhard A, Töpper M, Berger-Höger B, Steckelberg A, Fischer H, Vitinius F, Beifus K, Köberlein-Neu J, Wiedemann R, Rhiem K, Schmutzler R, Stock S.
    • Trials. 2020 Jun 8;21(1):501. doi: 10.1186/s13063-020-04431-x.
    • Changing practice: moving to a specialist nurse-led service for BRCA gene testing.
    • Scott N, O'Sullivan J, Asgeirsson K, Macmillan D, Wilson E.
    • Br J Nurs. 2020 May 28;29(10):S6-S13. doi: 10.12968/bjon.2020.29.10.S6.
    • Molecular Testing Updates and Impact for Clinical Practice.
    • Slane K.
    • NCCN. Continuing Education. 2020 May 8.
    • Systematic development of a training program for healthcare professionals to improve communication about breast cancer genetic counseling with low health literate patients.
    • van der Giessen JAM, Ausems MGEM, van den Muijsenbergh METC, van Dulmen S, Fransen MP.
    • Fam Cancer. 2020 Apr 22. doi: 10.1007/s10689-020-00176-3. [Epub ahead of print]
    • Mainstream consent programs for genetic counseling in cancer patients: A systematic review.
    • Scheinberg T, Young A, Woo H, Goodwin A, Mahon KL, Horvath LG.
    • Asia Pac J Clin Oncol. 2020 Apr 20. doi: 10.1111/ajco.13334. [Epub ahead of print]
    • NCCN Guidelines® Insights - Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020
    • NCCN Faculty
    • National Comprehensive Cancer Network. Continuing Education. Opens 2020 Apr 10. Exp 2021 Apr 10.
    • Continuing Education course

    Guidelines:

    NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.

    • Young Women With Breast Cancer: Treatment, Care, and Nursing Implications.
    • Corey B, Smania MA, Spotts H, Andersen M.
    • Clin J Oncol Nurs. 2020 Apr 1;24(2):139-147. doi: 10.1188/20.CJON.139-147.
    • Review
    • When to break the news and whose responsibility is it? A cross-sectional qualitative study of health professionals' views regarding disclosure of BRCA genetic cancer risk.
    • Young AL, Butow PN, Tucker KM, Wakefield CE, Healey E, Williams R.
    • BMJ Open. 2020 Feb 25;10(2):e033127. doi: 10.1136/bmjopen-2019-033127.
    • Health Care Provider Perceptions of Caring for Individuals with Inherited Pancreatic Cancer Risk.
    • Underhill ML, Pozzar R, Chung D, Sawhney M, Yurgelun M.
    • J Cancer Educ. 2020 Feb;35(1):194-203. doi: 10.1007/s13187-019-01623-1.
    • 'We don't know for sure': discussion of uncertainty concerning multigene panel testing during initial cancer genetic consultations.
    • Medendorp NM, Hillen MA, van Maarschalkerweerd PEA, Aalfs CM, Ausems MGEM, Verhoef S, van der Kolk LE, Berger LPV, Wevers MR, Wagner A, Caanen BAH, Stiggelbout AM, Smets EMA.
    • Fam Cancer. 2020 Jan;19(1):65-76. doi: 10.1007/s10689-019-00154-4. Epub 2019 Nov 26.
    • [Learning from My Experience: Outpatient Care for Cancer Multigene Genomic Testing].
    • Aimono E, Iguchi A, Mochida K, Imai M, Hayashi H, Nishihara H.
    • Yakugaku Zasshi. 2020;140(5):667-668. doi: 10.1248/yakushi.19-00217-4.
    • Conference abstract, [Article in Japanese]
    • [Our Treatment Strategy for Patients with Hereditary Breast Cancer Syndrome in Hamamatsu Medical Center].
    • Miyamoto Y, Tochikubo J, Hosokawa Y, Amano K.
    • Yakugaku Zasshi. 2020;140(5):669-671. doi: 10.1248/yakushi.19-00217-5.
    • Menopausal hormone therapy for BRCA-mutation carriers: attitudes of Israeli healthcare providers before and after a brief educational intervention.
    • Perri T, Farhadian Y, Friedman E, Korach J.
    • Menopause. 2019 Nov 4. doi: 10.1097/GME.0000000000001432. [Epub ahead of print]
    • Contraception options for patients with known hereditary risk for ovarian cancer.
    • Joy KM.
    • JAAPA. 2019 Nov;32(11):37-41. doi: 10.1097/01.JAA.0000586384.47435.31.
    • Review
    • Genetic and Genomic Advances in Breast Cancer Diagnosis and Treatment.
    • Walker-Smith TL, Peck J.
    • Nurs Womens Health. 2019 Oct 25. pii: S1751-4851(19)30188-6. doi: 10.1016/j.nwh.2019.09.003. [Epub ahead of print]
    • Review
    • Warranting the decision-maker, not the decision: How healthcare practitioners evaluate the legitimacy of patients' unprompted requests for risk-reducing mastectomy.
    • Brown SL, Beesley H, Holcombe C, Saini P, Salmon P.
    • Patient Educ Couns. 2019 Aug;102(8):1446-1451. doi: 10.1016/j.pec.2019.03.007. Epub 2019 Mar 18.
    • Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Prostate Cancer
    • Srinivas S, Shah SA.
    • NCCN Continuing Education. 2019 Jul 5.
    • CME Course
    • Breast Cancer Risk Prediction Models: Challenges in Clinical Application.
    • Paquin M, Fasolino T, Steck MB.
    • Clin J Oncol Nurs. 2019 Jun 1;23(3):256-259. doi: 10.1188/19.CJON.256-259.
    • Review
    • Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer.
    • Kemp Z, Turnbull A, Yost S, Seal S, Mahamdallie S, Poyastro-Pearson E, Warren-Perry M, Eccleston A, Tan MM, Teo SH, Turner N, Strydom A, George A, Rahman N.
    • JAMA Netw Open. 2019 May 3;2(5):e194428. doi: 10.1001/jamanetworkopen.2019.4428.
    • NCCN Guidelines® Insights - Breast Cancer, Version 3.2018.
    • Faculty
    • National Comprehensive Cancer Network. Continuing Education. 2019 Feb 2.
    • CME course

    Guidelines: NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): Breast Cancer — Version 4.2018 — February 8, 2019 (PDF) (National Comprehensive Cancer Network)

    • Genetic Service Delivery Models: Exploring Approaches to Care for Families With Hereditary Cancer Risk.
    • Pierle JM, Mahon SM.
    • Clin J Oncol Nurs. 2019 Feb 1;23(1):60-67. doi: 10.1188/19.CJON.60-67.
    • Guidelines-Based Cancer Risk Assessment.
    • Forman A, Schwartz S.
    • Semin Oncol Nurs. 2019 Feb;35(1):34-46. doi: 10.1016/j.soncn.2018.12.010. Epub 2019 Jan 22.
    • Hereditary Breast and Hereditary Ovarian Cancer: Implications for the Oncology Nurse.
    • Beamer LC.
    • Semin Oncol Nurs. 2019 Feb;35(1):47-57. doi: 10.1016/j.soncn.2018.12.001. Epub 2019 Jan 30.
    • No. 366-Gynaecologic Management of Hereditary Breast and Ovarian Cancer.
    • Jacobson M, Bernardini M, Sobel ML, Kim RH, McCuaig J, Allen L.
    • J Obstet Gynaecol Can. 2018 Nov;40(11):1497-1510. doi: 10.1016/j.jogc.2018.05.046.
    • Guidelines

    [Article in French]:

    No 366 - Prise en charge gynécologique du cancer du sein et de l'ovaire héréditaire.

    • Direct-to-consumer genetic testing for breast cancer risk.
    • Reed EK, Edelman EA.
    • J Am Assoc Nurse Pract. 2018 Oct;30(10):548-550. doi: 10.1097/JXX.0000000000000146.
    • Review
    • Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care.
    • Silverman TB, Vanegas A, Marte A, Mata J, Sin M, Ramirez JCR, Tsai WY, Crew KD, Kukafka R.
    • BMC Health Serv Res. 2018 Aug 13;18(1):633. doi: 10.1186/s12913-018-3442-x.
    • Timing and Mode of Breast Care Nurse Consultation From the Patient's Perspective.
    • Brown J, Refeld G, Cooper A.
    • Oncol Nurs Forum. 2018 May 1;45(3):389-398. doi: 10.1188/18.ONF.389-398.
    • The Relationship Between Body Image, Gender, Subjective Norms, and the Decision to Undergo Preventive Mastectomy Among Arab and Jewish BRCA Carriers.
    • Kardosh M, Bar-Tal Y, Barnoy S.
    • Cancer Nurs. 2018 May/Jun;41(3):255-262. doi: 10.1097/NCC.0000000000000503.
    • Knowledge Level and Educational Needs of Turkish Oncology Nurses Regarding the Genetics of Hereditary Breast and Ovarian Cancer.
    • Seven M, Pasalak SI, Guvenc G, Kok G.
    • J Contin Educ Nurs. 2017 Dec 1;48(12):570-576. doi: 10.3928/00220124-20171115-09.
    • Genetic Testing: Challenges and Changes in Testing for Hereditary Cancer Syndromes.
    • King E, Mahon SM.
    • Clin J Oncol Nurs. 2017 Oct 1;21(5):589-598. doi: 10.1188/17.CJON.589-598.
    • Current condition of genetic medicine for hereditary breast cancer.
    • Terui-Kohbata H, Yoshida M.
    • Mol Clin Oncol. 2017 Jul;7(1):98-102. doi: 10.3892/mco.2017.1260. Epub 2017 May 12.
    • Next Generation Sequencing and Multi-Gene Panel Testing: Implications for the Oncology Nurse.
    • Kelly PA.
    • Semin Oncol Nurs. 2017 May;33(2):208-218. doi: 10.1016/j.soncn.2017.02.007. Epub 2017 Apr 5.
    • Review
    • A collaborative approach to cancer risk assessment services using genetic counselor extenders in a multi-system community hospital.
    • Cohen SA, Nixon DM.
    • Breast Cancer Res Treat. 2016 Oct;159(3):527-34. doi: 10.1007/s10549-016-3964-z. Epub 2016 Aug 31.

    Comments from NSGC Discussion Forum Cancer SIG

    Subject: Assist physicians with ordering testing?

    • Women Need More Information to Cope With Aftermath of BRCA-Prompted Preventive Surgery.
    • Ellie Leick.
    • Oncology Nursing News. 2016 Aug 1
    • Are changes in breast self-exam recommendations and early misperceptions of breast cancer risk increasing women's future risks?
    • Polek C, Hardie T.
    • J Am Assoc Nurse Pract. 2016 Jul;28(7):379-86. doi: 10.1002/2327-6924.12325. Epub 2015 Nov 24.
    • The integration of BRCA testing into oncology clinics.
    • Percival N, George A, Gyertson J, Hamill M, Fernandes A, Davies E, Rahman N, Banerjee S.
    • Br J Nurs. 2016 Jun 23;25(12):690-4. doi: 10.12968/bjon.2016.25.12.690.
    • Use of a Point-of-Care Tool to Improve Nurse Practitioner BRCA Knowledge.
    • Smania M.
    • Clin J Oncol Nurs. 2016 Jun 1;20(3):327-31. doi: 10.1188/16.CJON.327-331.
    • Parental Decision Making Regarding the Disclosure or Nondisclosure of a Mutation-Positive BRCA1/2 Test Result to Minors.
    • Seenandan-Sookdeo KA, Hack TF, Lobchuk M, Murphy L, Marles S.
    • Oncol Nurs Forum. 2016 May 1;43(3):330-41. doi: 10.1188/16.ONF.330-341.
    • Why Women Are Choosing Bilateral Mastectomy.
    • Jerome-D'Emilia B, Suplee PD, D'Emilia I.
    • Clin J Oncol Nurs. 2015 Dec 1;19(6):764-8. doi: 10.1188/15.CJON.764-768.

    Free full text: Why Women Are Choosing Bilateral Mastectomy (Medscape Oncology)

    • Identifying Women at Risk for Hereditary Breast and Ovarian Cancer Syndrome Utilizing Breast Care Nurse Navigation at Mammography and Imaging Centers.
    • Appel SJ, Cleiment RJ.
    • J Natl Black Nurses Assoc. 2015 Dec;26(2):17-26.
    • Testing times for BRCA gene carriers.
    • Carlisle D.
    • Nurs Stand. 2015 Nov 11;30(11):17-9. doi: 10.7748/ns.30.11.17.s21.
    • Next-Generation Gene Sequencing: Looking Beyond Hereditary Breast and Ovarian Cancer.
    • Estrada SS, LeGrazie B, McKamie T2, Montgomery S.
    • Oncol Nurs Forum. 2015 Nov 1;42(6):691-4. doi: 10.1188/15.ONF.691-694.
    • A Woman's Decision to Choose Bilateral Mastectomy.
    • Jerome-D'Emilia B, Suplee PD, Boiler JL, D'Emilia JC.
    • Cancer Nurs. 2015 Nov-Dec;38(6):426-35. doi: 10.1097/NCC.0000000000000232.
    • Impact of a Nurse Navigator on Genomic Testing and Timely Treatment Decision Making in Patients With Breast Cancer.
    • McAllister KA, Schmitt ML.
    • Clin J Oncol Nurs. 2015 Oct 1;19(5):510-2. doi: 10.1188/15.CJON.510-512.

    Press: Impact of a Nurse Navigator on Genomic Testing and Timely Treatment Decision Making in Patients With Breast Cancer. (Medscape)

    • Breast Cancer Genetic Testing: More Than a Medical Management Tool.
    • Schroeder D, Conroy SA.
    • Clin J Oncol Nurs. 2015 Oct 1;19(5):603-7. doi: 10.1188/15.CJON.603-607.
    • Review
    • Ovarian cancer: Ensuring early diagnosis.
    • Slatnik CL, Duff E.
    • Nurse Pract. 2015 Sep 13;40(9):47-54. doi: 10.1097/01.NPR.0000450742.00077.a2.
    • Factors influencing breast cancer screening and risk assessment among young African American women: An integrative review of the literature.
    • Jones TP, Katapodi MC, Lockhart JS.
    • J Am Assoc Nurse Pract. 2015 Sep;27(9):521-9. doi: 10.1002/2327-6924.12223. Epub 2015 Mar 3.
    • Review
    • "The BRCA Responder" on Genetic Testing, Family Histories, and Why Counseling Is Key.
    • Kelly Johnson.
    • Oncology Nursing News. 2015 Aug 31.
    • Response to "biologic, demographic, and social factors affecting triple negative breast cancer outcomes".
    • [No authors listed]
    • Clin J Oncol Nurs. 2015 Jun;19(3):244. doi: 10.1188/15.CJON.244.
    • Comment, Letter

    Biologic, demographic, and social factors affecting triple negative breast cancer outcomes.

    • Breast Self-examination Education for BRCA Mutation Carriers by Clinical Nurse Specialists.
    • Visser A, Bos WC, Prins JB, Hoogerbrugge N, van Laarhoven HW.
    • Clin Nurse Spec. 2015 May-Jun;29(3):E1-E7.
    • The Consequences of a BRCA Mutation in Women.
    • Famorca-Tran J, Roux G.
    • J Adv Pract Oncol. 2015 May-Jun;6(3):194-210. Epub 2015 May 1.
    • Genetic tests to identify risk for breast cancer.
    • Lynch JA, Venne V, Berse B.
    • Semin Oncol Nurs. 2015 May;31(2):100-7. doi: 10.1016/j.soncn.2015.02.007. Epub 2015 Feb 26.
    • Review
    • Resources to increase genetics and genomics capacity of oncology nurses.
    • Aiello LB.
    • Oncol Nurs Forum. 2015 Mar 1;42(2):204-6. doi: 10.1188/15.ONF.204-206.
    • Knowledge about breast cancer and hereditary breast cancer among nurses in a public hospital.
    • Prolla CM, da Silva PS, Netto CB, Goldim JR, Ashton-Prolla P.
    • Rev Lat Am Enfermagem. 2015 Jan-Feb;23(1):90-7. doi: 10.1590/0104-1169.0185.2529.
    • Assessing and managing breast cancer risk: clinicians' current practice and future needs.
    • Collins IM, Steel E, Mann GB, Emery JD, Bickerstaffe A, Trainer A, Butow P, Pirotta M, Antoniou AC, Cuzick J, Hopper J, Phillips KA, Keogh LA.
    • Breast. 2014 Oct;23(5):644-50. doi: 10.1016/j.breast.2014.06.014. Epub 2014 Jul 4.
    • From the set-up of a screening program of breast cancer patients to the identification of the first BRCA mutation in the DR Congo.
    • Luyeye Mvila G, Postema S, Marchal G, Van Limbergen E, Verdonck F, Matthijs G, Devriendt K, Michils G, Van Ongeval C.
    • BMC Public Health. 2014 Jul 28;14:759. doi: 10.1186/1471-2458-14-759.
    • Genetic testing for BRCA1 and BRCA2 genes.
    • Kessenich CR, Bacher K, Moore PA.
    • Nurse Pract. 2014 Jun 15;39(6):8-10. doi: 10.1097/01.NPR.0000446876.99650.eb.
    • Review

    Comment, Letter:

    BRCA genetic testing: State of the science.

    • Risk assessment, genetic counseling, and clinical care for hereditary breast cancer.
    • Powers J, Stopfer JE.
    • J Obstet Gynecol Neonatal Nurs. 2014 May-Jun;43(3):361-73. doi: 10.1111/1552-6909.12304. Epub 2014 Apr 1.
    • Review
    • Providing care for previvors: implications for oncology nurses.
    • Mahon SM.
    • Clin J Oncol Nurs. 2014 Feb;18(1):21-4. doi: 10.1188/14.CJON.21-24.
    • Review, Case reports
    • Are we ready for personalized cancer risk management? The view from breast-care providers.
    • Komatsu H, Yagasaki K.
    • Int J Nurs Pract. 2014 Feb;20(1):39-45. doi: 10.1111/ijn.12115. Epub 2013 Jun 14.
    • BRCA Genetic Testing: An RN's Personal Story.
    • Wasserman L.
    • Clin J Oncol Nurs. 2013 Aug 1;17(4):449-50. doi: 10.1188/13.CJON.449-450.
    • Risk management: Jolie's decision sparks debate, need for more education.
    • Trossman S.
    • Am Nurse. 2013 Jul-Aug;45(4):1, 6.
    • Oncology health professionals' attitudes toward treatment-focused genetic testing for women newly diagnosed with breast cancer.
    • Burcher S, Meiser B, Mitchell G, Saunders C, Rahman B, Tucker K, Barlow-Stewart K, Watts K, Gleeson M, Kirk J.
    • Per Med. 2013 Jul;10(5):431-440. doi: 10.2217/pme.13.45.
    • Large Genomic Rearrangements in BRCA1 and BRCA2: Implications for Patient Care.
    • Mahon SM.
    • Oncol Nurs Forum. 2013 May 1;40(3):220-2. doi: 10.1188/13.ONF.220-222.

    Free Medscape-style version: Large Genomic Rearrangements in BRCA1 and BRCA2: Implications for Patient Care. (Medscape)

    • Communication and information needs of women diagnosed with ovarian cancer regarding treatment-focused genetic testing.
    • Gleeson M, Meiser B, Barlow-Stewart K, Trainer AH, Tucker K, Watts KJ, Friedlander M, Kasparian N.
    • Oncol Nurs Forum. 2013 May 1;40(3):275-83. doi: 10.1188/13.ONF.40-03AP.
    • Understanding the Needs of Women Considering Risk-Reducing Salpingo-oophorectomy.
    • Cherry C, Ropka M, Lyle J, Napolitano L, Daly MB.
    • Cancer Nurs. 2013 May-Jun;36(3):E33-8. doi: 10.1097/NCC.0b013e3182642cb5.
    • A statewide survey of practitioners to assess knowledge and clinical practices regarding hereditary breast and ovarian cancer.
    • Pal T, Cragun D, Lewis C, Doty A, Rodriguez M, Radford C, Thompson Z, Kim J, Vadaparampil ST.
    • Genet Test Mol Biomarkers. 2013 May;17(5):367-75. doi: 10.1089/gtmb.2012.0381. Epub 2013 Feb 28.
    • Being young, female, and BRCA positive.
    • Hamilton R.
    • Am J Nurs. 2012 Oct;112(10):26-31, quiz 46, 32.
    • Hereditary breast and ovarian cancer: research on how women respond to genetic testing.
    • Bingham R.
    • Nurs Womens Health. 2012 Aug-Sep;16(4):319-24. doi: 10.1111/j.1751-486X.2012.01750.x.
    • Surgical treatment differences among Latina and African American breast cancer survivors.
    • Campesino M, Koithan M, Ruiz E, Glover JU, Juarez G, Choi M, Krouse RS.
    • Oncol Nurs Forum. 2012 Jul;39(4):E324-31. doi: 10.1188/12.ONF.E324-E331.
    • Hereditary breast and ovarian cancer.
    • Barks P, Goldgar C.
    • JAAPA. 2012 Mar;25(3):63-5.
    • Review
    • Getting to the point: what women newly diagnosed with breast cancer want to know about treatment-focused genetic testing.
    • Meiser B, Gleeson M, Watts K, Peate M, Zilliacus E, Barlow-Stewart K, Saunders C, Mitchell G, Kirk J.
    • Oncol Nurs Forum. 2012 Mar;39(2):E101-11. doi: 10.1188/12.ONF.E101-E111.